Jonathan Romeo, DO
Allergy & Immunology · Raleigh, NCNPI 1821250283
Payments from drug & device makers
Across 578 payments — averaging $484.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$241K
- Optinose US, Inc.$29K
- AbbVie$2K
- Genentech USA, Inc.$2K
- Sanofi$1K
- Regeneron Healthcare Solutions, Inc.$1K
- plus $4K from 22 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 258 | $240,596 |
| Optinose US, Inc. | 46 | $29,416 |
| AbbVie | 10 | $2,274 |
| Genentech USA, Inc. | 9 | $1,546 |
| Sanofi | 14 | $1,343 |
| Regeneron Healthcare Solutions, Inc. | 50 | $1,003 |
| Amgen | 90 | $913 |
| GSK | 24 | $429 |
| Aimmune Therapeutics, Inc. | 4 | $381 |
| Novartis | 9 | $350 |
| Pfizer | 14 | $270 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $255 |
| CSL Behring | 7 | $183 |
| ARS Pharmaceuticals Operations, Inc. | 3 | $148 |
| Biocryst US Sales Co., LLC | 5 | $142 |
| Grifols USA, LLC | 5 | $118 |
| Kaleo, Inc. | 6 | $99 |
| Genentech, Inc. | 1 | $82 |
| Galderma Laboratories, L.p. | 1 | $63 |
| Organon | 3 | $59 |
| Sanofi-aventis U.S. LLC | 1 | $46 |
| Lilly USA, LLC | 2 | $38 |
| Shire North American Group Inc | 1 | $20 |
| Philips North America LLC | 1 | $18 |
| Cycle Pharmaceuticals Inc | 1 | $17 |
| Alk-abello, Inc | 1 | $16 |
| Hikma Pharmaceuticals USA | 1 | $13 |
| Merck | 1 | $12 |
How this compares
$279,848 in reported general payments places this provider in the 90th percentile of 140 allergy & immunology providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other allergy & immunology in Raleigh
- Craig LaforceRaleigh$7.9M
- Karen DunnRaleigh$3.3M
- Laurie McWilliamsRaleigh$155K
- Sonia BainsRaleigh$23K
- Gurvinder DeogunRaleigh$14K
- Maureen PetersenRaleigh$13K
- Heather GutekunstRaleigh$12K
- Maeve OconnorCharlotte$2.2M
- David CypcarAsheville$1.6M
- Edwin KimChapel Hill$874K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.